Short Synthetic β‐Sheet Forming Peptide Amphiphiles as Broad Spectrum Antimicrobials with Antibiofilm and Endotoxin Neutralizing Capabilities
- 26 February 2013
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 23 (29) , 3682-3692
Abstract
Although naturally occurring membrane lytic antimicrobial peptides (AMPs) and their analogs hold enormous promise for antibiotics‐resistant infectious disease therapies, significant challenges such as systemic toxicities, long peptide sequences, poor understanding of structure‐activity relationships, and the potential for compromising innate host defense immunity have greatly limited their clinical applicability. To improve the clinical potential of AMPs, a facile approach is adopted to design a series of short synthetic β‐sheet folding peptide amphiphiles comprised of short recurring (X1Y1X2Y2)n‐NH2 sequences, where X1 and X2: hydrophobic residues (Val, Ile, Phe or Trp), Y1 and Y2: cationic residues (Arg or Lys), and n: number of repeat units; with systematic variations to the cationic and hydrophobic residues to obtain optimized AMP sequences bearing minimal resemblance to naturally occurring sequences. The designed β‐sheet forming peptides exhibit broad spectrum antimicrobial activities against various clinically relevant microorganisms, including Gram‐positive Staphylococcus epidermidis and Staphylococcus aureus, Gram‐negative Escherichia coli and Pseudomonas aeruginosa, and yeast Candida albicans, with excellent selectivities for microbial membranes. Optimal synthetic peptides with n = 2 and n = 3 repeat units, i.e., (IRIK)2‐NH2 and (IRVK)3‐NH2, efficiently inhibit sessile biofilm bacteria growth leading to biomass reduction. Additionally, sequences with n = 3 repeat units effectively neutralize endotoxins while causing minimal cytotoxicities. Taken together, these findings clearly demonstrate that the rationally designed synthetic β‐sheet folding peptides are highly selective, non‐cytotoxic at antimicrobial levels and have tremendous potential for use as broad spectrum antimicrobial agents to overcome multidrug resistance in a wide range of localized, systemic, or external therapeutic applications.Keywords
This publication has 31 references indexed in Scilit:
- The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm FormationInternational Journal of Molecular Sciences, 2011
- Rational Design of α‐Helical Antimicrobial Peptides to Target Gram‐negative Pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: Utilization of Charge, ‘Specificity Determinants,’ Total Hydrophobicity, Hydrophobe Type and Location as Design Parameters to Improve the Therapeutic RatioChemical Biology & Drug Design, 2011
- Mammalian cell toxicity and candidacidal mechanism of Arg- or Lys-containing Trp-rich model antimicrobial peptides and their d-enantiomeric peptidesPeptides, 2010
- Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide AnalogsPLOS ONE, 2010
- Antimicrobial peptides: linking partition, activity and high membrane-bound concentrationsNature Reviews Microbiology, 2009
- APD2: the updated antimicrobial peptide database and its application in peptide designNucleic Acids Research, 2008
- Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptidesPeptide Science, 2008
- Antimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNature Biotechnology, 2006
- How can a β‐sheet peptide be both a potent antimicrobial and harmfully toxic? Molecular dynamics simulations of protegrin‐1 in micellesPeptide Science, 2005
- Design of synthetic bactericidal peptides derived from the bactericidal domain P18–39 of aprotininBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1999